12:00 AM
 | 
Jan 28, 2013
 |  BC Week In Review  |  Company News  |  Other News

Recombinetics, NIH cardiovascular news

Recombinetics said it will deliver to academic partners the first set of genetically modified pig models of atherosclerosis. Recombinetics said it received a $318,000 grant from NIH "a little more than a year...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >